StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued to clients and investors on Thursday. The firm set a “hold” rating on the software maker’s stock.
Separately, Stephens upped their price objective on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, January 31st.
View Our Latest Stock Analysis on MDRX
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Recommended Stories
- Five stocks we like better than Veradigm
- Do ETFs Pay Dividends? What You Need to Know
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Golden Cross Stocks: Pattern, Examples and Charts
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
